Publications by authors named "Andrew Antoszyk"

Claim this Profile
E
Efficacy of Topical Non-Selective and COX-2 Selective NSAIDs in Accelerating Resolution of Acute Central Serous Chorioretinopathy: A Retrospective Analysis.
Preston O'Brien, Michael A Singer, Darren J Bell, Abigail Diamond, Allison Kim, Andrew N Antoszyk

Clin Ophthalmol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in activity impairment and work productivity after treatment for vitreous hemorrhage due to proliferative diabetic retinopathy: Secondary outcomes from a randomized controlled trial (DRCR Retina Network Protocol AB).
Wesley T Beaulieu, Maureen G Maguire, Andrew N Antoszyk,

PLoS One· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time.
Dennis M Marcus, Paolo S Silva, Danni Liu, Lloyd Paul Aiello, Andrew Antoszyk

JAMA Ophthalmol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time.
Paolo S Silva, Dennis M Marcus, Danni Liu, Lloyd Paul Aiello, Andrew Antoszyk

JAMA Ophthalmol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial.
Raj K Maturi, Adam R Glassman, Kristin Josic, Andrew N Antoszyk, Barbara A Blodi

JAMA Ophthalmol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
Adam R Glassman, Wesley T Beaulieu, Maureen G Maguire, Andrew N Antoszyk, Clement C Chow

JAMA Ophthalmol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Andrew N Antoszyk, Adam R Glassman, Wesley T Beaulieu, Lee M Jampol, Chirag D Jhaveri

JAMA· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema.
Andrew N Antoszyk, Kathleen Wade Tarnowski, Karen Basu, Jason S Ehrlich, Zdenka Haskova

Ophthalmol Retina· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study).
Adam R Glassman, John A Wells, Kristin Josic, Maureen G Maguire, Andrew N Antoszyk

Ophthalmology· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular Degeneration.
Pravin U Dugel, David S Boyer, Andrew N Antoszyk, Nathan C Steinle, Michael P Varenhorst

Ophthalmol Retina· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.
Tiarnan D Keenan, Susan Vitale, Elvira Agrón, Amitha Domalpally, Andrew N Antoszyk

Ophthalmol Retina· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Pacman" invasion of the retina: Two cases of ophthalmomyiasis interna posterior.
Omar S Punjabi, David J Browning, Loraine Clark, Andrew N Antoszyk

Am J Ophthalmol Case Rep· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usability of the Ranibizumab 0.5 mg Prefilled Syringe: Human Factors Studies to Evaluate Critical Task Completion by Healthcare Professionals.
Andrew N Antoszyk, Carl Baker, Jorge Calzada, Howard Cummings, Joanna So

PDA J Pharm Sci Technol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
Carl W Baker, Adam R Glassman, Wesley T Beaulieu, Andrew N Antoszyk, David J Browning

JAMA· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Jeffrey G Gross, Adam R Glassman, Danni Liu, Jennifer K Sun, Andrew N Antoszyk

JAMA Ophthalmol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy.
David G Birch, Matthew S Benz, Daniel M Miller, Andrew N Antoszyk, Joseph Markoff

Retina· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.
Ingrid U Scott, Paul C VanVeldhuisen, Michael S Ip, Barbara A Blodi, Neal L Oden, Andrew N Antoszyk

JAMA Ophthalmol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.
John A Wells, Adam R Glassman, Lee M Jampol, Lloyd Paul Aiello, Andrew N Antoszyk

JAMA Ophthalmol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

JAMA· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.
Lloyd Paul Aiello, Allison R Ayala, Andrew N Antoszyk, Bambi Arnold-Bush, Carl Baker

JAMA Ophthalmol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

N Engl J Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.

JAMA Ophthalmol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detachable microsphere scalpel tips for potential use in ophthalmic surgery with the erbium:YAG laser.
Thomas C Hutchens, Arash Darafsheh, Amir Fardad, Andrew N Antoszyk, Howard S Ying

J Biomed Opt· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.

JAMA Ophthalmol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of novel microsphere chain fiber optic tips for potential use in ophthalmic laser surgery.
Thomas C Hutchens, Arash Darafsheh, Amir Fardad, Andrew N Antoszyk, Howard S Ying

J Biomed Opt· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis